Literature DB >> 23921741

Obesity Notches up fatty liver.

Michael P Czech1.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23921741     DOI： 10.1038/nm.3293

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  14 in total

1.  Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways.

Authors:  Jessica L Yecies; Hui H Zhang; Suchithra Menon; Sihao Liu; Derek Yecies; Alex I Lipovsky; Cem Gorgun; David J Kwiatkowski; Gökhan S Hotamisligil; Chih-Hao Lee; Brendan D Manning
Journal:  Cell Metab       Date:  2011-07-06       Impact factor: 27.287

Review 2.  Sending the right signal: Notch and stem cells.

Authors:  Carolina N Perdigoto; Allison J Bardin
Journal:  Biochim Biophys Acta       Date:  2012-08-16

Review 3.  The multifaceted role of mTORC1 in the control of lipid metabolism.

Authors:  Stéphane J H Ricoult; Brendan D Manning
Journal:  EMBO Rep       Date:  2012-02-12       Impact factor: 8.807

Review 4.  Regulation of innate and adaptive immunity by Notch.

Authors:  Freddy Radtke; H Robson MacDonald; Fabienne Tacchini-Cottier
Journal:  Nat Rev Immunol       Date:  2013-05-13       Impact factor: 53.106

Review 5.  Notch inhibition as a promising new approach to cancer therapy.

Authors:  Benjamin Purow
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

6.  Notch ligand delta-like 4 blockade attenuates atherosclerosis and metabolic disorders.

Authors:  Daiju Fukuda; Elena Aikawa; Filip K Swirski; Tatiana I Novobrantseva; Victor Kotelianski; Cem Z Gorgun; Aleksey Chudnovskiy; Hiroyuki Yamazaki; Kevin Croce; Ralph Weissleder; Jon C Aster; Gökhan S Hotamisligil; Hideo Yagita; Masanori Aikawa
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-13       Impact factor: 11.205

7.  Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner.

Authors:  Utpal B Pajvani; Carrie J Shawber; Varman T Samuel; Andreas L Birkenfeld; Gerald I Shulman; Jan Kitajewski; Domenico Accili
Journal:  Nat Med       Date:  2011-07-31       Impact factor: 53.440

8.  Notch activation induces endothelial cell senescence and pro-inflammatory response: implication of Notch signaling in atherosclerosis.

Authors:  Zhao-Jun Liu; Yurong Tan; Gary W Beecham; David M Seo; Runxia Tian; Yan Li; Roberto I Vazquez-Padron; Margaret Pericak-Vance; Jeffery M Vance; Pascal J Goldschmidt-Clermont; Alan S Livingstone; Omaida C Velazquez
Journal:  Atherosclerosis       Date:  2012-05-18       Impact factor: 5.162

Review 9.  Selective versus total insulin resistance: a pathogenic paradox.

Authors:  Michael S Brown; Joseph L Goldstein
Journal:  Cell Metab       Date:  2008-02       Impact factor: 27.287

10.  Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis.

Authors:  Sudha B Biddinger; Antonio Hernandez-Ono; Christian Rask-Madsen; Joel T Haas; José O Alemán; Ryo Suzuki; Erez F Scapa; Chhavi Agarwal; Martin C Carey; Gregory Stephanopoulos; David E Cohen; George L King; Henry N Ginsberg; C Ronald Kahn
Journal:  Cell Metab       Date:  2008-02       Impact factor: 27.287
View more
  8 in total

1.  The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis.

Authors:  Peng Zhang; Pi-Xiao Wang; Ling-Ping Zhao; Xin Zhang; Yan-Xiao Ji; Xiao-Jing Zhang; Chun Fang; Yue-Xin Lu; Xia Yang; Mao-Mao Gao; Yan Zhang; Song Tian; Xue-Yong Zhu; Jun Gong; Xin-Liang Ma; Feng Li; Zhihua Wang; Zan Huang; Zhi-Gang She; Hongliang Li
Journal:  Nat Med       Date:  2017-12-11       Impact factor: 53.440

2.  Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4.

Authors:  Guang-Nian Zhao; Peng Zhang; Jun Gong; Xiao-Jing Zhang; Pi-Xiao Wang; Miao Yin; Zhou Jiang; Li-Jun Shen; Yan-Xiao Ji; Jingjing Tong; Yutao Wang; Qiao-Fang Wei; Yong Wang; Xue-Yong Zhu; Xin Zhang; Jing Fang; Qingguo Xie; Zhi-Gang She; Zhihua Wang; Zan Huang; Hongliang Li
Journal:  Nat Med       Date:  2017-05-08       Impact factor: 53.440

Review 3.  Crystallographic mining of ASK1 regulators to unravel the intricate PPI interfaces for the discovery of small molecule.

Authors:  Ashish Kumar Agrahari; Madhu Dikshit; Shailendra Asthana
Journal:  Comput Struct Biotechnol J       Date:  2022-07-11       Impact factor: 6.155

4.  Whole-body and hepatic insulin resistance in obese children.

Authors:  Lorena del Rocío Ibarra-Reynoso; Liudmila Pisarchyk; Elva Leticia Pérez-Luque; Ma Eugenia Garay-Sevilla; Juan Manuel Malacara
Journal:  PLoS One       Date:  2014-11-20       Impact factor: 3.240

5.  Maternal Food Restriction during Pregnancy and Lactation Adversely Affect Hepatic Growth and Lipid Metabolism in Three-Week-Old Rat Offspring.

Authors:  Sangmi Lee; Young-Ah You; Eun Jin Kwon; Sung-Chul Jung; Inho Jo; Young Ju Kim
Journal:  Int J Mol Sci       Date:  2016-12-15       Impact factor: 5.923

6.  Effects of Karela (Bitter Melon; Momordica charantia) on genes of lipids and carbohydrates metabolism in experimental hypercholesterolemia: biochemical, molecular and histopathological study.

Authors:  Dalia Yossri Saad; Mohamed Mohamed Soliman; Ahmed A Baiomy; Magdy Hassan Yassin; Hanan Basiouni El-Sawy
Journal:  BMC Complement Altern Med       Date:  2017-06-17       Impact factor: 3.659

7.  Targeting arginase-II protects mice from high-fat-diet-induced hepatic steatosis through suppression of macrophage inflammation.

Authors:  Chang Liu; Angana G Rajapakse; Erwin Riedo; Benoit Fellay; Marie-Claire Bernhard; Jean-Pierre Montani; Zhihong Yang; Xiu-Fen Ming
Journal:  Sci Rep       Date:  2016-02-05       Impact factor: 4.379

8.  Interleukin-22 drives a metabolic adaptive reprogramming to maintain mitochondrial fitness and treat liver injury.

Authors:  Wei Chen; Wenjing Zai; Jiajun Fan; Xuyao Zhang; Xian Zeng; Jingyun Luan; Yichen Wang; Yilan Shen; Ziyu Wang; Shixuan Dai; Si Fang; Zhen Zhao; Dianwen Ju
Journal:  Theranostics       Date:  2020-04-27       Impact factor: 11.556
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.